ru3 -适配体纳米粒子的自组装通过NADH的光氧化还原催化和溶酶体破坏引发焦亡

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
Shenting Zhang, Xufeng Zhu, Wenzhu Yu, Yunjiang Yu, Li qian, Zhikai Chen, Zitong Peng, Lijun Gao*, Lanmei Chen* and Jincan Chen*, 
{"title":"ru3 -适配体纳米粒子的自组装通过NADH的光氧化还原催化和溶酶体破坏引发焦亡","authors":"Shenting Zhang,&nbsp;Xufeng Zhu,&nbsp;Wenzhu Yu,&nbsp;Yunjiang Yu,&nbsp;Li qian,&nbsp;Zhikai Chen,&nbsp;Zitong Peng,&nbsp;Lijun Gao*,&nbsp;Lanmei Chen* and Jincan Chen*,&nbsp;","doi":"10.1021/acs.jmedchem.5c0002210.1021/acs.jmedchem.5c00022","DOIUrl":null,"url":null,"abstract":"<p >Photodynamic therapy (PDT) can induce tumor cell death. <b>Ru3</b>, a metal-based photosensitizer, features a high positive charge, a long triplet excited-state lifetime, and an excellent PDT activity. The aptamer AS1411, known for its ability to selectively bind to nucleolin (which is overexpressed in tumor cells), self-assembled with <b>Ru3</b> into nanoparticles termed <b>Ru3ApNPs</b>. These nanoparticles specifically target SiHa tumor cells. Upon light irradiation, <b>Ru3ApNPs</b> increase intracellular ROS levels, catalyze NADH redox reactions, and induce lysosomal disruption, ultimately triggering pyroptosis in tumor cells. Notably, <b>Ru3ApNPs</b> demonstrate excellent tumor penetration in 3D multicellular spheroids (MCSs) of SiHa cells and effectively inhibit their growth under light exposure. <b>Ru3ApNPs</b> exhibit a mechanism of action distinct from that of traditional PDT. Furthermore, under light irradiation, <b>Ru3ApNPs</b> can effectively inhibit the growth of distant tumors and induce systemic immune responses in mice. Our data suggest that <b>Ru3ApNPs</b> can be developed as promising targeted therapeutic agents in the future.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"68 11","pages":"11017–11038 11017–11038"},"PeriodicalIF":6.8000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Self-Assembly of Ru3-Aptamer Nanoparticles Triggers Pyroptosis through Photoredox Catalysis of NADH and Lysosomal Disruption\",\"authors\":\"Shenting Zhang,&nbsp;Xufeng Zhu,&nbsp;Wenzhu Yu,&nbsp;Yunjiang Yu,&nbsp;Li qian,&nbsp;Zhikai Chen,&nbsp;Zitong Peng,&nbsp;Lijun Gao*,&nbsp;Lanmei Chen* and Jincan Chen*,&nbsp;\",\"doi\":\"10.1021/acs.jmedchem.5c0002210.1021/acs.jmedchem.5c00022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Photodynamic therapy (PDT) can induce tumor cell death. <b>Ru3</b>, a metal-based photosensitizer, features a high positive charge, a long triplet excited-state lifetime, and an excellent PDT activity. The aptamer AS1411, known for its ability to selectively bind to nucleolin (which is overexpressed in tumor cells), self-assembled with <b>Ru3</b> into nanoparticles termed <b>Ru3ApNPs</b>. These nanoparticles specifically target SiHa tumor cells. Upon light irradiation, <b>Ru3ApNPs</b> increase intracellular ROS levels, catalyze NADH redox reactions, and induce lysosomal disruption, ultimately triggering pyroptosis in tumor cells. Notably, <b>Ru3ApNPs</b> demonstrate excellent tumor penetration in 3D multicellular spheroids (MCSs) of SiHa cells and effectively inhibit their growth under light exposure. <b>Ru3ApNPs</b> exhibit a mechanism of action distinct from that of traditional PDT. Furthermore, under light irradiation, <b>Ru3ApNPs</b> can effectively inhibit the growth of distant tumors and induce systemic immune responses in mice. Our data suggest that <b>Ru3ApNPs</b> can be developed as promising targeted therapeutic agents in the future.</p>\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"68 11\",\"pages\":\"11017–11038 11017–11038\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00022\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00022","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

光动力疗法(PDT)可诱导肿瘤细胞死亡。钌是一种金属基光敏剂,具有高正电荷、长三重态激发态寿命和优异的PDT活性。适体AS1411以其选择性结合核蛋白(在肿瘤细胞中过度表达)的能力而闻名,与Ru3自组装成称为Ru3ApNPs的纳米颗粒。这些纳米颗粒专门针对SiHa肿瘤细胞。在光照射下,Ru3ApNPs增加细胞内ROS水平,催化NADH氧化还原反应,诱导溶酶体破坏,最终引发肿瘤细胞焦亡。值得注意的是,Ru3ApNPs在SiHa细胞的3D多细胞球体(MCSs)中表现出良好的肿瘤穿透性,并在光照下有效抑制其生长。Ru3ApNPs表现出与传统PDT不同的作用机制。此外,在光照下,Ru3ApNPs可以有效抑制小鼠远处肿瘤的生长并诱导全身免疫反应。我们的数据表明,Ru3ApNPs可以作为未来有前景的靶向治疗药物开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Self-Assembly of Ru3-Aptamer Nanoparticles Triggers Pyroptosis through Photoredox Catalysis of NADH and Lysosomal Disruption

Self-Assembly of Ru3-Aptamer Nanoparticles Triggers Pyroptosis through Photoredox Catalysis of NADH and Lysosomal Disruption

Photodynamic therapy (PDT) can induce tumor cell death. Ru3, a metal-based photosensitizer, features a high positive charge, a long triplet excited-state lifetime, and an excellent PDT activity. The aptamer AS1411, known for its ability to selectively bind to nucleolin (which is overexpressed in tumor cells), self-assembled with Ru3 into nanoparticles termed Ru3ApNPs. These nanoparticles specifically target SiHa tumor cells. Upon light irradiation, Ru3ApNPs increase intracellular ROS levels, catalyze NADH redox reactions, and induce lysosomal disruption, ultimately triggering pyroptosis in tumor cells. Notably, Ru3ApNPs demonstrate excellent tumor penetration in 3D multicellular spheroids (MCSs) of SiHa cells and effectively inhibit their growth under light exposure. Ru3ApNPs exhibit a mechanism of action distinct from that of traditional PDT. Furthermore, under light irradiation, Ru3ApNPs can effectively inhibit the growth of distant tumors and induce systemic immune responses in mice. Our data suggest that Ru3ApNPs can be developed as promising targeted therapeutic agents in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信